Abstract:Abstract Background and Aims Alternative splicing (AS) is a known key factor in gene regulation. There is evidence that changes in the alternative mRNA splicing can lead to the onset of various diseases. However, the potential role of AS in the pathogenesis of glomerular diseases has only been investigated to a very limited extent. In the past, the zebrafish larva (Danio rerio) has been established as an animal model for the in vivo investigation of kidney diseases, since the glomeruli of zebrafish larvae are genetically, molecularly, and functionally similar to those of mammals. As part of the Sys_CARE (Systems Medicine Investigation of AS in Cardiac and Renal Diseases) project, we wanted to identify specific AS events that might be involved in the development of focal segmental glomerulosclerosis (FSGS). Method For all experiments, the double transgenic strain [Tg (nphs2: GAL4-VP16); (UAS:Eco.nfsB-mCherry)] was used. At 4 dpf (days post fertilization), the zebrafish larvae were divided into two groups. The control group was treated with 0.1% dimethyl sulfoxide (DMSO) in E3 medium. To induce FSGS, zebrafish larvae were treated with 50 nM nifurpirinol (NFP) in 0.1% DMSO in E3 medium for 24 hours. Glomeruli were manually isolated at 5 and 6 dpf and analyzed together with lysates of whole larvae by LC-MS/MS and RNA-Seq. To identify AS events, RNA-Seq data were analyzed by MAJIQ, Multivariate Analysis of Transcript Splicing (rMATS), leafcutter, Whippet as well as IsoformSwitchAnalyzeR. Gene set enrichment analysis (GSEA) identified proteins and genes which were classified according to their related biological processes. Results Proteomics and transcriptomics showed significant differences in the glomerular protein and transcript levels between NFP-treated larvae and the control group. The abundance of the podocyte-specific protein nephrin as well as the podocin promotor-driven expression of the fluorescent dye mCherry was significantly reduced after NFP treatment confirming the onset of the injury. Subsequent analyses identified more than 1000 transcripts that were significantly differentially expressed, as well as several splicing events in the larvae with a FSGS-like damage. There was also a marked shift in isoform patterns in larvae with FSGS. Gene set enrichment analysis indicated an enrichment in the up-regulated transcripts and proteins involved in metabolic processes, especially those related to rRNA and ncRNA processing. Conversely, transcripts and proteins that were down-regulated showed significant clusters in catabolic processes, extracellular matrix, and cytoskeleton organization as well as in nephron and glomerulus development. Conclusion Using our zebrafish model, in-depth transcriptomics and proteomics analysis provided novel insights into the pathogenesis of podocyte-associated glomerular diseases. Data suggest, that pathological changes are accompanied by alternative splice events which might therefore be a new therapeutic approach in glomerular nephropathy.

Multi-omics analyses of early-onset familial Alzheimer's disease and Sanfilippo syndrome zebrafish models reveal commonalities in disease mechanisms

Zebrafish models of Mucopolysaccharidosis types IIIA, B, & C show hyperactivity and changes in oligodendrocyte state

Brain transcriptome analysis of a familial Alzheimer’s disease-like mutation in the zebrafish presenilin 1 gene implies effects on energy production

Functional investigation of the gliovascular niche‐related genes and their relevance to Alzheimer’s disease pathomechanisms in zebrafish

Aluminum Chloride and D-galactose Induced a Zebrafish Model of Alzheimer's Disease with Cognitive Deficits and Aging

Mucopolysaccharidosis type II zebrafish model exhibits early impaired proteasomal-mediated degradation of the axon guidance receptor Dcc

Drosophila melanogaster models of MPS IIIC (Hgsnat‐deficiency) highlight the role of glia in disease presentation

A disease similarity approach identifies short-lived Niemann-Pick type C disease mice with accelerated brain aging as a novel mouse model for Alzheimer's disease and aging research

Transcriptome analysis of -null zebrafish embryos elucidates possible disease mechanisms

Presenilin-1 Targeted Morpholino Induces Cognitive Deficits, Increased Brain Aβ1-42 and Decreased Synaptic Marker PSD-95 in Zebrafish Larvae

#2407 Multiomics analysis of isolated zebrafish glomeruli to unravel the impact of alternative splicing in glomerular diseases

Advancing Alzheimer's Research With Zebrafish Models: Current Insights, Addressing Challenges, and Charting Future Courses

High-throughput functional analysis of autism genes in zebrafish identifies convergence in dopaminergic and neuroimmune pathways

Generation and characterization of a zebrafish gain-of-function ACOX1 Mitchell disease model

Experimental Zebrafish Models of Mitochondrial Dysfunction in the Pathogenesis of CNS Diseases

Deciphering Early and Progressive Molecular Signatures in Alzheimer's Disease through Integrated Longitudinal Proteomic and Pathway Analysis in a Rodent Model

Behavioural pharmacology predicts disrupted signalling pathways and candidate therapeutics from zebrafish mutants of Alzheimer's disease risk genes

Stable primary brain cell cultures from zebrafish reveal hyperproliferation of non-neuronal cells from scn1lab mutants

Zebrafish CCNF and FUS Mediate Stress-Specific Motor Responses

An Integrative Multi‐Omics Approach Reveals Molecular Signatures Associated with Age and High‐Fat Diet in Mouse Models of Alzheimer’s Disease

Deep multilayer brain proteomics identifies molecular networks and Netrin‐1 accumulation in Alzheimer’s disease progression: Genetics/omics and systems biology